Half-Dose DOACs Cut Bleeding, Thrombus Risk Post-Watchman Implant Half-Dose DOACs Cut Bleeding, Thrombus Risk Post-Watchman Implant
The risks dropped off sharply after standard postprocedure antithrombotics were replaced by a half-dose DOAC given indefinitely without long-term antiplatelets in an observational study.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 15, 2021 Category: Cardiology Tags: Cardiology News Source Type: news
World Thrombosis Day raises worldwide awareness of an urgent and growing health problem – blood clots
World Thrombosis Day (WTD) is a year-long campaign that focuses attention on the underappreciated condition of thrombosis, or blood clots. Unfortunately, one in four people worldwide die each year from conditions caused by thrombosis. Currently, the World Health Assembly has a global target in place to reduce premature deaths from non-communicable disease by 25 percent by 2025 and 30 percent by 2030. Unless thrombosis is addressed on a global scale, achieving this goal will be impossible.
“Despite… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 13, 2021 Category: Biotechnology Authors: International Society on Thrombosis and Hemostasis (ISTH) Source Type: news
Hypercoagulability and Thrombosis in COVID-19 Hypercoagulability and Thrombosis in COVID-19
A new study provides valuable insights into the manifestations of pulmonary embolism in patients with COVID-19, and may help clarify the routine use of anticoagulant strategies in COVID-19 patients.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 11, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
EU Finds J & J COVID Shot Possibly Linked to Another Rare Clotting Condition EU Finds J & J COVID Shot Possibly Linked to Another Rare Clotting Condition
The European Union ' s drug regulator on Friday identified a possible link between rare cases of venous thromboembolism with Johnson& Johnson ' s COVID-19 vaccine and recommended the condition be listed as a side effect of the shot.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - October 4, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news
CVST After COVID-19 Vaccine: New Data Confirm High Mortality Rate CVST After COVID-19 Vaccine: New Data Confirm High Mortality Rate
A new series of cases of cerebral venous sinus thrombosis (CVST) linked to the adenoviral vector COVID-19 vaccines has been reported, confirming the severity of the reaction and the associated high mortality.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 30, 2021 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news
New Phase 3 Data Suggest Positive Effect and Show Similar Safety with XARELTO ® (rivaroxaban) Compared to Aspirin in Pediatric Fontan Procedure Patients at Risk for Blood Clots and Blood Clot-Related Events
RARITAN, NJ, September 27, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data from the Phase 3 UNIVERSE study showing treatment with XARELTO® (rivaroxaban) in an oral suspension formulation, compared to treatment with aspirin, was associated with numerically fewer blood clots and clinical events strongly associated with blood clots in pediatric patients (aged 2-8 years) who have undergone the Fontan procedure. [1] These findings, which were published this month in the Journal of the American Heart Association and included in a recent New Drug Application submitted to the U.S. F...
Source: Johnson and Johnson - September 27, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Delayed-onset portal venous thrombosis after ingestion of 3% hydrogen peroxide - Schneir A, Minns AB, Otter J.
BACKGROUND: Identification of portal venous gas on radiographic imaging is well documented after the ingestion of hydrogen peroxide, as is its resolution after hyperbaric therapy. Although hyperbaric therapy may resolve the gastrointestinal symptoms associ... (Source: SafetyLit)
Source: SafetyLit - September 16, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Decompressive Surgery Saves Lives in Severe Cerebral Vein Thrombosis Decompressive Surgery Saves Lives in Severe Cerebral Vein Thrombosis
For patients with large hemorrhagic brain lesions caused by CVT, who are at a very high risk for death, decompressive surgery was associated with remarkably good outcomes in the DECOMPRESS2 study.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 15, 2021 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news
Blood clot symptoms: The marking on your leg that could signal deep vein thrombosis
DEEP vein thrombosis occurs when a blood clot forms in a deep vein, usually in a person's leg. A pulmonary embolism happens when the blood clot breaks off and travels from the leg up to the lungs. This means it is important to be aware of the signs on your leg. (Source: Daily Express - Health)
Source: Daily Express - Health - September 15, 2021 Category: Consumer Health News Source Type: news
Study Describes Bleeding Risk With Anticoagulants for VTE Study Describes Bleeding Risk With Anticoagulants for VTE
New research may help doctors assess the long-term risk for major bleeding if anticoagulation for unprovoked venous thromboembolism (VTE) is continued beyond 3 –6 months.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - September 14, 2021 Category: Primary Care Tags: Internal Medicine News Source Type: news
Guidance from the Expert Haematology Panel (EHP) on Covid-19 Vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT), British Society for Haematology
Updated Guidance on Management. Version 2.2 31 August 2021 (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 13, 2021 Category: Consumer Health News Source Type: news
Comparison of three interventional approaches to prevent ventilator-associated pneumonia in intensive care units (ICUs): A clinical trial study
Background: Ventilator-associated pneumonia (VAP) is an infectious pulmonary disease that develops after 48 hours of ventilation. To date, several methods have been proposed to reduce VAP occurrence, such as the VAP prevention bundle, which involves raising the head of the bed, reducing sedation, avoiding deep vein thrombosis, and preventing peptic ulcer in the gastrointestinal system. The purpose of this study was to evaluate the role of personnel in hand washing, case airway suctioning, and systematic monitoring in the prevention of VAP.; Methods: In the current clinical trial, 129 patients hospitalized and intubated at ...
Source: Current Awareness Service for Health (CASH) - September 9, 2021 Category: Consumer Health News Source Type: news
